Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study

TSH and thyroid hormones might not affect ovarian cancer risk. However, high fT4 and low TSH concentrations may be associated with poorer survival. Further evaluation is suggested in other populations.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-08-11
DOI
https://doi.org/10.1093/jnci/djaf222
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study

Carine Biessy, Sabina Rinaldi, Thérèse Truong, Ruth C. Travis et al.
JNCI Journal of the National Cancer Institute
Ovarian cancer diagnosis and treatment
article

Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study

Carine Biessy, Sabina Rinaldi, Thérèse Truong, Ruth C. Travis, Claudia Vener, Matthias Bernd Schulze, A. Fournier, ­Rosario ­Tumino, Fulvio Ricceri, Béatrice Vozar, Charlotte Le Cornet, Giovanna Masala, Renée T. Fortner, Marcela Guevara, Elio Ríboli, Sandra M. Colorado‐Yohar, Pernilla Israelsson, Azam Majidi, Marta Crous‐Bou, Camilla Panico, María‐José Sánchez, Laure Dossus
article en

Abstract

TSH and thyroid hormones might not affect ovarian cancer risk. However, high fT4 and low TSH concentrations may be associated with poorer survival. Further evaluation is suggested in other populations.

JNCI Journal of the National Cancer InstituteVol. 117(11)
Norwegian Institute of Public Health (NO), Harvard University (US), Inserm (FR), University of Potsdam (DE), German Cancer Research Center (DE), Université de Versailles Saint-Quentin-en-Yvelines (FR), Heidelberg University (DE), Université Paris-Saclay (FR), Prevention Institute (US), Institut Gustave Roussy (FR), Bellvitge University Hospital (ES), Agostino Gemelli University Polyclinic (IT), Universidad de Antioquia (CO), University of Oxford (GB), Instituto de Salud Pública de Navarra (ES), Institut d'Investigació Biomédica de Bellvitge (ES), University of Ragusa (IT), Advanced Radiation Therapy (United States) (US), Centre de recherche en Epidémiologie et Santé des Populations (FR), Institut Català d'Oncologia (ES), Navarre Institute of Health Research (ES), Instituto de Investigación Biosanitaria de Granada (ES), Italian Association for Cancer Research (IT), Cancer Registry of Norway (NO), Instituto Murciano de Investigación Biosanitaria (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Department of Public Health (US), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), German Institute of Human Nutrition (DE), Centre international de recherche sur le cancer (FR), Imperial College London (GB), Andalusian School of Public Health (ES), Umeå University (SE)
Good health and well-being
Openalex Percentile: Top 72%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.